Timothy Daley
Stock Analyst at Wells Fargo
(2.61)
# 2,061
Out of 4,784 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $39.85 | +17.14% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $8.88 | +125.23% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $105.62 | -10.05% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $42.08 | +71.10% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $116.69 | +24.26% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,177.09 | +10.44% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $362.16 | -21.31% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $205.85 | +19.99% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $155.55 | +76.79% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $230.02 | +17.38% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $8.64 | +224.07% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.29 | +72.50% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $500.16 | +3.97% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $2.15 | +318.60% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $133.41 | +38.67% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $61.32 | +38.62% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $177.39 | +24.02% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $179.07 | +22.86% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $16.18 | +73.05% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $167.33 | -16.33% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $58.73 | +53.24% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $39.85
Upside: +17.14%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $8.88
Upside: +125.23%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $105.62
Upside: -10.05%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $42.08
Upside: +71.10%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $116.69
Upside: +24.26%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,177.09
Upside: +10.44%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $362.16
Upside: -21.31%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $205.85
Upside: +19.99%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $155.55
Upside: +76.79%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $230.02
Upside: +17.38%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $8.64
Upside: +224.07%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.29
Upside: +72.50%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $500.16
Upside: +3.97%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $2.15
Upside: +318.60%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $133.41
Upside: +38.67%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $61.32
Upside: +38.62%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $177.39
Upside: +24.02%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $179.07
Upside: +22.86%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $16.18
Upside: +73.05%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $167.33
Upside: -16.33%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $58.73
Upside: +53.24%